mondo_id	mondo_label	xref	xref_source	original_label	definition	parents
ID	LABEL	A oboInOwl:hasDbXref	>A oboInOwl:source SPLIT=|		A IAO:0000115	SC %
MONDO:0956962	benign teratoma	DOID:0080602	MONDO:equivalentTo	benign teratoma	A germ cell benign neoplasm that derives_from mature tissue elements or a limited amount of immature tissue elements.	MONDO:0850144
MONDO:0956964	medulloblastoma shh activated and tp53 mutant	DOID:0080704	MONDO:equivalentTo	medulloblastoma SHH activated and TP53 mutant	A medulloblastoma SHH activated that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and the presence of TP53 mutations.	MONDO:0850197
MONDO:0956965	medulloblastoma shh activated and tp53 wild-type	DOID:0080705	MONDO:equivalentTo	medulloblastoma SHH activated and TP53 wild-type	A medulloblastoma SHH activated that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and the absence of TP53 mutations.	MONDO:0850197
MONDO:0956966	medulloblastoma non-wnt/non-shh group 3	DOID:0080707	MONDO:equivalentTo	medulloblastoma non-WNT/non-SHH group 3	A medulloblastoma non-WNT/non-SHH that is characterized as a molecular subtype by absent TP53 mutations and MYC amplifications that may be present.	MONDO:0850198
MONDO:0956967	medulloblastoma non-wnt/non-shh group 4	DOID:0080708	MONDO:equivalentTo	medulloblastoma non-WNT/non-SHH group 4	A medulloblastoma non-WNT/non-SHH that is characterized as a molecular subtype by the absence of MYC amplifications and TP53 mutations, while chromosome 17 abnormalities may be present.	MONDO:0850198
MONDO:0956968	gene duplication disease	DOID:0080712	MONDO:equivalentTo	gene duplication disease	A monogenic disease that is the result of a mutation that involves the production of one or more copies of a gene.	MONDO:0000275
MONDO:0956969	chronic inducible urticaria	DOID:0080748	MONDO:equivalentTo	chronic inducible urticaria	A chronic urticaria that is characterized by a history of a consistent stimulus that initiates lesions, which are typically short-lived and fleeting, lasting a few minutes up to 2 hours.	MONDO:0850230
MONDO:0956970	chronic spontaneous urticaria	DOID:0080749	MONDO:equivalentTo	chronic spontaneous urticaria	A chronic urticaria that is characterized by urticaria independent of any exogenous stimulus.	MONDO:0850230
MONDO:0956971	intermittent asthma	DOID:0080812	MONDO:equivalentTo	intermittent asthma	A chronic asthma that is characterized by severity with symptoms two or fewer days per week, nighttime awakenings two or fewer times per month, use of short-acting beta agonist for symptom control two or fewer days per week and no interference with normal activity.	MONDO:0850282
MONDO:0956972	persistent mild asthma	DOID:0080813	MONDO:equivalentTo	persistent mild asthma	A chronic asthma that is characterized by severity with symptoms two or more days per week, nighttime awakenings three to four times per month, use of short-acting beta agonist for symptom control two or more days per week and minor limitation of normal activity.	MONDO:0850282
MONDO:0956973	persistent moderate asthma	DOID:0080814	MONDO:equivalentTo	persistent moderate asthma	A chronic asthma that is characterized by severity with daily symptoms, nighttime awakenings more than once per week, daily use of short-acting beta agonist for symptom control and some limitation of normal activity.	MONDO:0850282
MONDO:0956974	adult-onset severe asthma	DOID:0080816	MONDO:equivalentTo	adult-onset severe asthma	A chronic asthma that is characterized by first presentation in adulthood.	MONDO:0850282
MONDO:0956975	t2-high asthma	DOID:0080817	MONDO:equivalentTo	T2-high asthma	A chronic asthma that is characterized by the pathophysiology phenotype combination (endotype) of early-onset allergic asthma, late-onset eosinophilic asthma, and aspirin-exacerbated respiratory disease.	MONDO:0850282
MONDO:0956976	t2-low asthma	DOID:0080818	MONDO:equivalentTo	T2-low asthma	A chronic asthma that is characterized by the pathophysiology phenotype combination (endotype) of non-atopic, smoking, obesity related, and elderly and that is characterized by neutrophilic (sputum neutrophils > 40–60%) or paucigranulocytic (i.e., normal sputum levels of both eosinophils and neutrophils) inflammation and a lack of response to corticosteroid therapy.	MONDO:0850282
MONDO:0956977	near-fatal asthma	DOID:0080823	MONDO:equivalentTo	near-fatal asthma	An acute asthma that is characterized by a respiratory arrest or arterial carbon dioxide tension greater than 50 mmHg, with or without altered consciousness, requiring mechanical ventilation.	MONDO:0850283
MONDO:0956978	persistent severe asthma	DOID:0080824	MONDO:equivalentTo	persistent severe asthma	A chronic asthma that is characterized by severity with symptoms two or fewer days per week, nighttime awakenings two or fewer times per month, use of short-acting beta agonist for symptom control several times per day and extremely limited normal activity.	MONDO:0850282
MONDO:0956979	nocturnal asthma	DOID:0080826	MONDO:equivalentTo	nocturnal asthma	A chronic asthma that is characterized by significant decline in pulmonary function and increase of airway inflammation at night. During sleep, recumbent posture causes a reduction in the lung volumes, respiratory muscle tone, and lung compliance. The overnight physiological abnormalities include: increased airway inflammation and decreased steroid responsiveness, increased pulmonary capillary blood volume, functional differences in blood/air volume ratios and mechanical coupling of the parenchyma to the airways.	MONDO:0850282
MONDO:0956980	vascular parkinsonism	DOID:0080856	MONDO:equivalentTo	vascular Parkinsonism	A Parkinsonism that is characterized by postural instability, a broad-based gait with the absence of tremors of vascular origin.	MONDO:0021095
MONDO:0956981	astrocytoma, idh-mutant, grade 4	DOID:0080877	MONDO:equivalentTo	astrocytoma, IDH-mutant, grade 4	An IDH-mutant anaplastic astrocytoma that is characterized by the presence of necrosis and/or microvascular proliferation or homozygous deletion of CDKN2A and/or CDKN2B genes. The term glioblastoma no longer applies to central nervous system WHO grade 4 IDH-mutant astrocytomas.	MONDO:0850332
MONDO:0956983	pleomorphic xanthoastrocytoma braf mutant	DOID:0080881	MONDO:equivalentTo	pleomorphic xanthoastrocytoma BRAF mutant	An anaplastic pleomorphic xanthoastrocytoma that has_material_basis_in BRAF mutations.	MONDO:0850312
MONDO:0956984	yap1-mamld1 fusion-positive supratentorial ependymoma	DOID:0080891	MONDO:equivalentTo	YAP1-MAMLD1 fusion-positive supratentorial ependymoma	A supratentorial ependymoma that has_material_basis_in YAP1-MAMLD1 fusion.	MONDO:0850340
MONDO:0956985	lipofibromatosis-like neural tumor	DOID:0080894	MONDO:equivalentTo	lipofibromatosis-like neural tumor	A connective tissue cancer that has_material_basis_in LMNA-NTRK1 gene fusion.	MONDO:0002176
MONDO:0956986	solitary fibrous tumor/hemangiopericytoma	DOID:0080897	MONDO:equivalentTo	solitary fibrous tumor/hemangiopericytoma	A connective tissue cancer that is characterized as the combination of solitary fibrous tumors and hemangiopericytomas.	MONDO:0002176
MONDO:0956987	ezb-myc+ diffuse large b-cell lymphoma	DOID:0081070	MONDO:equivalentTo	EZB-MYC+ diffuse large B-cell lymphoma	An EZB diffuse large B-cell lymphoma that expresses the double hit gene expression signature (DHITsig+) according to gene expression profiling. In addition to the features characteristic of EZB, these cases commonly, but do not always, harbour MYC translocations and DDX3X mutations.	MONDO:0850469
MONDO:0956988	ezb-myc- diffuse large b-cell lymphoma	DOID:0081071	MONDO:equivalentTo	EZB-MYC- diffuse large B-cell lymphoma	An EZB diffuse large B-cell lymphoma that does not express the double hit gene expression signature (DHITsig-) according to gene expression profiling. These cases tend to have few MYC translocations or DDX3X mutations.	MONDO:0850469
MONDO:0956989	cic-rearranged sarcoma	DOID:0081250	MONDO:equivalentTo	CIC-rearranged sarcoma	An EWSERI-negative small round cell tumor that is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and either DUX4 gene on chromosome 4 or DUX4L gene on chromosome 10. The translocation results in either CIC-DUX4, t(4;19)(q35;q13) or CIC-DUX4L, t(10;19)(q26;q13) fusions.	MONDO:0858921
MONDO:0956990	supratentorial ependymoma, zfta fusion–positive	DOID:0081252	MONDO:equivalentTo	supratentorial ependymoma, ZFTA fusion–positive	A suptratentorial ependymoma that is characterized by the presence of a fusion gene involving ZFTA gene.	MONDO:0850340
MONDO:0956991	supratentorial ependymoma, yap1 fusion–positive	DOID:0081253	MONDO:equivalentTo	supratentorial ependymoma, YAP1 fusion–positive	A supratentorial ependymoma that is characterized by the presence of a fusion gene involving YAP1 gene.	MONDO:0850340
MONDO:0956992	posterior fossa group a ependymoma	DOID:0081254	MONDO:equivalentTo	posterior fossa group A ependymoma	A posterior fossa ependymoma that arises in the posterior fossa with characteristic DNA methylation patterns, including CpG island hypermethylation, global DNA hypomethylation, reduction of nuclear H3 p.K28me3 (K27me3) expression, and EZHIP overexpression.	MONDO:0850339
MONDO:0956993	posterior fossa group b ependymoma	DOID:0081255	MONDO:equivalentTo	posterior fossa group B ependymoma	A posterior fossa ependymoma that arises in the posterior fossa with characteristic DNA methylation patterns including retention of nuclear H3 p.K28me3 (K27me3) expression, absence of CpG island hypermethylation, absence of global DNA hypomethylation, and absence of EZHIP overexpression.	MONDO:0850339
MONDO:0956994	astrocytoma, idh-mutant, grade 2	DOID:0081256	MONDO:equivalentTo	astrocytoma, IDH-mutant, grade 2	An IDH-mutant anaplastic astrocytoma that is characterized by the presence of well-differentiated fibrillary glial cells diffusely infiltrating the central nervous system.	MONDO:0850332
MONDO:0956995	astrocytoma, idh-mutant, grade 3	DOID:0081257	MONDO:equivalentTo	astrocytoma, IDH-mutant, grade 3	An IDH-mutant anaplastic astrocytoma that is characterized by the presence of increased mitotic activity and anaplastic features.	MONDO:0850332
MONDO:0956996	oligodendroglioma, idh-mutant and 1p/19q-codeleted grade 2	DOID:0081281	MONDO:equivalentTo	oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2	An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as a well differentiated tumor lacking anaplastic features (brisk mitotic activity, microvascular proliferation, necrosis).	MONDO:0859592
MONDO:0956997	oligodendroglioma, idh-mutant and 1p/19q-codeleted, grade 3	DOID:0081282	MONDO:equivalentTo	oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3	An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as grade 3 tumors associated with a more rapid growth. Grade 3 tumors appear to have abnormalities on chromosomes 9 or 10, along with unusual amounts of growth factors and proteins, which are thought to contribute to the more rapid growth of these gliomas.	MONDO:0859592
MONDO:0957118	bradyopsia 2	DOID:0070364	MONDO:equivalentTo	bradyopsia 2		MONDO:0012033
MONDO:0957120	nevoid basal cell carcinoma syndrome 2	DOID:0070366	MONDO:equivalentTo	nevoid basal cell carcinoma syndrome 2		MONDO:0007187
MONDO:0957121	leukoencephalopathy with vanishing white matter 5	DOID:0070367	MONDO:equivalentTo	leukoencephalopathy with vanishing white matter 5		MONDO:0800448
MONDO:0957122	leukoencephalopathy with vanishing white matter 4	DOID:0070371	MONDO:equivalentTo	leukoencephalopathy with vanishing white matter 4		MONDO:0800448
MONDO:0957123	leukoencephalopathy with vanishing white matter 3	DOID:0070372	MONDO:equivalentTo	leukoencephalopathy with vanishing white matter 3		MONDO:0800448
MONDO:0957124	leukoencephalopathy with vanishing white matter 2	DOID:0070373	MONDO:equivalentTo	leukoencephalopathy with vanishing white matter 2		MONDO:0800448
MONDO:0957127	developmental and epileptic encephalopathy 31b	DOID:0070376	MONDO:equivalentTo	developmental and epileptic encephalopathy 31B		MONDO:0100062|MONDO:0006025
MONDO:0957181	epidermolytic hyperkeratosis 2	DOID:0081359	MONDO:equivalentTo	epidermolytic hyperkeratosis 2	An epidermolytic hyperkeratosis that is characterized by generalized erythema, erosions, scaling, and easily breaking blisters that become less frequent later in life, while hyperkeratosis increases and that has_material_basis_in heterozygous or homozygous mutation in the keratin-10 gene (KRT10) on chromosome 17q21.	MONDO:0007239
MONDO:0957195	digenic disease	DOID:0080578	MONDO:equivalentTo	digenic disease		
MONDO:0957196	diffuse midline glioma, h3 k27m-mutant	DOID:0080684	MONDO:equivalentTo	diffuse midline glioma, H3 K27M-mutant	A histone mutated tumor that is characterized by the presence of histone H3 K27M mutation located throughout the midline structures of the central nervous system.	
MONDO:0957197	diffuse glioma, h3 g34 mutant	DOID:0080880	MONDO:equivalentTo	diffuse glioma, H3 G34 mutant	A histone mutated tumor that has_material_basis_in mutations in codon 34 of the H3 histone family 3A protein.	
MONDO:0957327	congenital myopathy 20	DOID:0081352	MONDO:equivalentTo	congenital myopathy 20	A congenital myopathy that has_material_basis_in homozygous or compound heterozygous mutation in the RYR3 gene on chromosome 15q13 and that shows wide phenotypic variability. Some patients present in early childhood with proximal muscle weakness affecting the lower and upper limbs resulting in difficulties running and climbing, whereas others present soon after birth with congenital limb or distal contractures.	MONDO:0019952|MONDO:0006025
MONDO:0957328	congenital myopathy 21	DOID:0081353	MONDO:equivalentTo	congenital myopathy 21	A congenital myopathy that is characterized by diaphragmatic weakness and spinal rigidity and that has_material_basis_in homozygous mutation in the DNAJB4 gene on chromosome 1p31.	MONDO:0019952|MONDO:0006025
MONDO:0957329	congenital myopathy 22a	DOID:0081354	MONDO:equivalentTo	congenital myopathy 22A	A congenital myopathy that is characterized by onset of muscle weakness in utero or soon after birth and that has_material_basis_in homozygous or compound heterozygous mutation in the SCN4A gene on chromosome 17q23. Biallelic mutation in the SCN4A gene also causes severe fetal congenital myopathy 22B.	MONDO:0019952|MONDO:0006025
MONDO:0957330	congenital myopathy 22b	DOID:0081355	MONDO:equivalentTo	congenital myopathy 22B	A congenital myopathy that is characterized by in utero onset of severe muscle weakness manifest as fetal akinesia and that has_material_basis_in homozygous or compound heterozygous mutation in the SCN4A gene on chromosome 17q23.	MONDO:0019952|MONDO:0006025
MONDO:0957353	progressive leukoencephalopathy with ovarian failure	DOID:0070396	MONDO:equivalentTo	progressive leukoencephalopathy with ovarian failure		MONDO:0019046|MONDO:0006025
MONDO:0957354	combined oxidative phosphorylation deficiency 44	DOID:0070424	MONDO:equivalentTo	combined oxidative phosphorylation deficiency 44		MONDO:0006025|MONDO:0000732
MONDO:0957355	combined oxidative phosphorylation deficiency 52	DOID:0070425	MONDO:equivalentTo	combined oxidative phosphorylation deficiency 52		MONDO:0000732|MONDO:0006025
MONDO:0957356	combined oxidative phosphorylation deficiency 53	DOID:0070426	MONDO:equivalentTo	combined oxidative phosphorylation deficiency 53		MONDO:0000732|MONDO:0006025
MONDO:0957357	combined oxidative phosphorylation deficiency 54	DOID:0070427	MONDO:equivalentTo	combined oxidative phosphorylation deficiency 54		MONDO:0000732|MONDO:0006025
MONDO:0957358	combined oxidative phosphorylation deficiency 55	DOID:0070428	MONDO:equivalentTo	combined oxidative phosphorylation deficiency 55		MONDO:0000732|MONDO:0000429
MONDO:0957359	combined oxidative phosphorylation deficiency 56	DOID:0070429	MONDO:equivalentTo	combined oxidative phosphorylation deficiency 56		MONDO:0000732|MONDO:0006025
MONDO:0957360	combined oxidative phosphorylation deficiency 57	DOID:0070430	MONDO:equivalentTo	combined oxidative phosphorylation deficiency 57		MONDO:0000732|MONDO:0006025
MONDO:0957361	hyperphosphatasia with impaired intellectual development syndrome	DOID:0070431	MONDO:equivalentTo	hyperphosphatasia with impaired intellectual development syndrome		MONDO:0019502
MONDO:0957362	retinal macular dystrophy	DOID:0070438	MONDO:equivalentTo	retinal macular dystrophy		MONDO:0003004|MONDO:0000426
MONDO:0957363	paroxysmal nonkinesigenic dyskinesia 3	DOID:0070442	MONDO:equivalentTo	paroxysmal nonkinesigenic dyskinesia 3		MONDO:0003441|MONDO:0000426
MONDO:0957364	neurodevelopmental disorder with cerebellar atrophy and motor dysfunction	DOID:0070443	MONDO:equivalentTo	neurodevelopmental disorder with cerebellar atrophy and motor dysfunction		MONDO:0019502
MONDO:0957365	neurodevelopmental disorder with language delay and seizures	DOID:0070444	MONDO:equivalentTo	neurodevelopmental disorder with language delay and seizures		MONDO:0019502
MONDO:0957366	early-onset dystonia and/or spastic paraplegia	DOID:0070445	MONDO:equivalentTo	early-onset dystonia and/or spastic paraplegia		MONDO:0003441|MONDO:0000426
MONDO:0957367	mitochondrial dna depletion syndrome 16	DOID:0070446	MONDO:equivalentTo	mitochondrial DNA depletion syndrome 16		MONDO:0018158|MONDO:0006025
MONDO:0957368	mitochondrial dna depletion syndrome 16b	DOID:0070447	MONDO:equivalentTo	mitochondrial DNA depletion syndrome 16B		MONDO:0018158|MONDO:0006025
MONDO:0957369	mitochondrial dna depletion syndrome 17	DOID:0070448	MONDO:equivalentTo	mitochondrial DNA depletion syndrome 17		MONDO:0018158|MONDO:0006025
MONDO:0957370	mitochondrial dna depletion syndrome 18	DOID:0070449	MONDO:equivalentTo	mitochondrial DNA depletion syndrome 18		MONDO:0018158|MONDO:0006025
MONDO:0957371	mitochondrial dna depletion syndrome 19	DOID:0070450	MONDO:equivalentTo	mitochondrial DNA depletion syndrome 19		MONDO:0018158|MONDO:0006025
MONDO:0957372	mitochondrial dna depletion syndrome 20	DOID:0070451	MONDO:equivalentTo	mitochondrial DNA depletion syndrome 20		MONDO:0018158|MONDO:0006025
MONDO:0957378	ladd syndrome	DOID:0081370	MONDO:equivalentTo	LADD syndrome	A syndrome that is characterized by defects in the tear-producing lacrimal system, ear problems, dental abnormalities, and deformities of the fingers.	MONDO:0002254
MONDO:0957500	xanthinuria type i	DOID:0070452	MONDO:equivalentTo	xanthinuria type I		MONDO:0018106
MONDO:0957501	xanthinuria type ii	DOID:0070453	MONDO:equivalentTo	xanthinuria type II		MONDO:0018106
MONDO:0957502	hereditary spastic paraplegia 70	DOID:0070454	MONDO:equivalentTo	hereditary spastic paraplegia 70		MONDO:0019064|MONDO:0006025
MONDO:0957503	hereditary spastic paraplegia 79a	DOID:0070455	MONDO:equivalentTo	hereditary spastic paraplegia 79A		MONDO:0019064|MONDO:0000426
MONDO:0957504	hereditary spastic paraplegia 87	DOID:0070456	MONDO:equivalentTo	hereditary spastic paraplegia 87		MONDO:0019064|MONDO:0006025
MONDO:0957505	hereditary spastic paraplegia 88	DOID:0070457	MONDO:equivalentTo	hereditary spastic paraplegia 88		MONDO:0019064|MONDO:0000426
MONDO:0957506	hereditary spastic paraplegia 89	DOID:0070458	MONDO:equivalentTo	hereditary spastic paraplegia 89		MONDO:0019064|MONDO:0006025
MONDO:0957507	hereditary spastic paraplegia 90a	DOID:0070459	MONDO:equivalentTo	hereditary spastic paraplegia 90A		MONDO:0019064|MONDO:0000426
MONDO:0957508	hereditary spastic paraplegia 90b	DOID:0070460	MONDO:equivalentTo	hereditary spastic paraplegia 90B		MONDO:0019064|MONDO:0000426
MONDO:0957509	mitochondrial complex v (atp synthase) deficiency nuclear type 4a	DOID:0070461	MONDO:equivalentTo	mitochondrial complex V (ATP synthase) deficiency nuclear type 4A		MONDO:0014091|MONDO:0000426
MONDO:0957510	mitochondrial complex v (atp synthase) deficiency nuclear type 4b	DOID:0070462	MONDO:equivalentTo	mitochondrial complex V (ATP synthase) deficiency nuclear type 4B		MONDO:0014091|MONDO:0006025
MONDO:0957511	mitochondrial complex v (atp synthase) deficiency nuclear type 5	DOID:0070463	MONDO:equivalentTo	mitochondrial complex V (ATP synthase) deficiency nuclear type 5		MONDO:0014471|MONDO:0006025
MONDO:0957512	mitochondrial complex v (atp synthase) deficiency nuclear type 7	DOID:0070464	MONDO:equivalentTo	mitochondrial complex V (ATP synthase) deficiency nuclear type 7		MONDO:0014471|MONDO:0006025
MONDO:0957513	carpal tunnel syndrome 1	DOID:0070466	MONDO:equivalentTo	carpal tunnel syndrome 1		MONDO:0007275|MONDO:0000426
MONDO:0957514	carpal tunnel syndrome 2	DOID:0070467	MONDO:equivalentTo	carpal tunnel syndrome 2		MONDO:0007275|MONDO:0000426
MONDO:0957516	anauxetic dysplasia 1	DOID:0050640	MONDO:equivalentTo	anauxetic dysplasia 1		MONDO:0011773|MONDO:0006025
MONDO:0957517	congenital disorder of glycosylation type iie	DOID:0070257	MONDO:equivalentTo	congenital disorder of glycosylation type IIe		MONDO:0005501|MONDO:0006025
MONDO:0957518	orofacial cleft 7	DOID:0080400	MONDO:equivalentTo	orofacial cleft 7		MONDO:0006025|MONDO:0000358
MONDO:0957519	diffuse gastric cancer	DOID:0080763	MONDO:equivalentTo	diffuse gastric cancer	A stomach cancer that is characterized by development of diffuse (signet ring cell) gastric cancer underneath the stomach lining.	MONDO:0001056
MONDO:0957520	disabling pansclerotic morphea	DOID:0081373	MONDO:equivalentTo	disabling pansclerotic morphea	A localized scleroderma that is characterized by the rapid progression of deep cutaneous fibrosis or pansclerosis that involves the subcutaneous adipose tissue and, occasionally, the fascia, muscles, and bone.	MONDO:0019562
MONDO:0957521	nemaline myopathy 5b	DOID:0081374	MONDO:equivalentTo	nemaline myopathy 5B	A nemaline myopathy that has_material_basis_in autosomal recessive inheritance of a homozygous or compound heterozygous mutation in the TNNT1 gene on chromosome 19q13, with childhood onset.	MONDO:0018958|MONDO:0006025
MONDO:0957522	nemaline myopathy 5c	DOID:0081375	MONDO:equivalentTo	nemaline myopathy 5C	A nemaline myopathy that has_material_basis_in autosomal dominant inheritance of a homozygous or compound heterozygous mutation in the TNNT1 gene on chromosome 19q13.	MONDO:0018958|MONDO:0000426
MONDO:0957523	sorbitol dehydrogenase deficiency with peripheral neuropathy	DOID:0081376	MONDO:equivalentTo	sorbitol dehydrogenase deficiency with peripheral neuropathy	A neuromuscular disease that is characterized by onset of distal muscle weakness mainly affecting the lower limbs and resulting in difficulty walking and that has_material_basis_in homozygous or compound heterozygous mutation in the SORD gene on chromosome 15q21.	MONDO:0019056|MONDO:0006025
MONDO:0957524	cox deficiency, benign infantile mitochondrial myopathy	DOID:0081377	MONDO:equivalentTo	COX deficiency, benign infantile mitochondrial myopathy	A cytochrome-c oxidase deficiency disease characterized by localization to tissues of the skeletal muscles.	MONDO:0009068
MONDO:0957525	kyphosis	DOID:4667	MONDO:equivalentTo	kyphosis		MONDO:0000836|MONDO:0000812
MONDO:0957558	li-fraumeni syndrome 1	DOID:0111503	MONDO:equivalentTo	Li-Fraumeni syndrome 1		MONDO:0018875
MONDO:0957605	spinocerebellar ataxia with axonal neuropathy type 3	DOID:0070465	MONDO:equivalentTo	spinocerebellar ataxia with axonal neuropathy type 3		MONDO:0015244
MONDO:0957606	yoon-bellen neurodevelopmental syndrome	DOID:0070468	MONDO:equivalentTo	Yoon-Bellen neurodevelopmental syndrome		MONDO:0002254|MONDO:0006025
MONDO:0957607	neurodevelopmental disorder with dysmorphic facies and thin corpus callosum	DOID:0070469	MONDO:equivalentTo	neurodevelopmental disorder with dysmorphic facies and thin corpus callosum		MONDO:0015802
MONDO:0957608	early-onset epilepsy 2	DOID:0070471	MONDO:equivalentTo	early-onset epilepsy 2		MONDO:0005027|MONDO:0000426
MONDO:0957609	early-onset epilepsy 3	DOID:0070472	MONDO:equivalentTo	early-onset epilepsy 3		MONDO:0005027|MONDO:0000426
MONDO:0957610	renal medullary carcinoma	DOID:0070475	MONDO:equivalentTo	renal medullary carcinoma		MONDO:0005086
MONDO:0957611	diphthamide deficiency syndrome	DOID:0070476	MONDO:equivalentTo	diphthamide deficiency syndrome		MONDO:0006025|MONDO:0004736
MONDO:0957612	schwannomatosis 1	DOID:0070480	MONDO:equivalentTo	schwannomatosis 1		MONDO:0008075
MONDO:0957613	schwannomatosis 2	DOID:0070481	MONDO:equivalentTo	schwannomatosis 2		MONDO:0008075
MONDO:0957614	spinal neurofibromatosis	DOID:0070482	MONDO:equivalentTo	spinal neurofibromatosis		MONDO:0018975
MONDO:0957615	watson syndrome	DOID:0070483	MONDO:equivalentTo	Watson syndrome		MONDO:0021060|MONDO:0000426
MONDO:0957616	legius syndrome	DOID:0070484	MONDO:equivalentTo	Legius syndrome		MONDO:0021060|MONDO:0000426
MONDO:0957617	amyotrophic lateral sclerosis type 24	DOID:0081378	MONDO:equivalentTo	amyotrophic lateral sclerosis type 24	An amyotrophic lateral sclerosis that is characterized by adult-onset loss of motor neurons and that has_material_basis_in heterozygous mutation in the NEK1 gene on chromosome 4q33.	MONDO:0004976|MONDO:0000426
MONDO:0957618	amyotrophic lateral sclerosis type 25	DOID:0081379	MONDO:equivalentTo	amyotrophic lateral sclerosis type 25	An amyotrophic lateral sclerosis that is characterized by rapidly progressive muscle weakness and death due to respiratory failure and that has_material_basis_in heterozygous mutation in the KIF5A gene on chromosome 12q13. ALS25 may have a lower median age at onset (46.5 years) and longer median survival (10 years) than that found in epidemiologic studies (62.5 years and 20 to 30 months, respectively).	MONDO:0004976|MONDO:0000426
MONDO:0957619	amyotrophic lateral sclerosis type 26	DOID:0081380	MONDO:equivalentTo	amyotrophic lateral sclerosis type 26	An amyotrophic lateral sclerosis that is characterized by adult onset of upper and low motor neuron disease causing bulbar dysfunction and limb weakness and that has_material_basis_in heterozygous mutation in the TIA1 gene on chromosome 2p13.	MONDO:0004976|MONDO:0000426
MONDO:0957620	juvenile amyotrophic lateral sclerosis type 27	DOID:0081381	MONDO:equivalentTo	juvenile amyotrophic lateral sclerosis type 27	An amyotrophic lateral sclerosis that is characterized by early childhood-onset lower extremity spasticity manifesting as toe walking and gait abnormalities, followed by progressive lower motor neuron-mediated weakness without sensory signs or symptoms and that has_material_basis_in heterozygous mutation in the SPTLC1 gene on chromosome 9q22.	MONDO:0004976|MONDO:0000426
MONDO:0957621	amyotrophic lateral sclerosis type 28	DOID:0081382	MONDO:equivalentTo	amyotrophic lateral sclerosis type 28	An amyotrophic lateral sclerosis that is characterized by adult onset of slowly progressive limb muscle weakness and atrophy resulting in gait difficulties, loss of ambulation, and distal upper limb weakness and that has_material_basis_in a heterozygous trinucleotide repeat expansion (CGG) in the 5-prime untranslated region of the LRP12 gene on chromosome 8q22.	MONDO:0004976|MONDO:0000426
MONDO:0957847	sotos syndrome 1	DOID:0112103	MONDO:equivalentTo	Sotos syndrome 1		MONDO:0019349|MONDO:0000426
MONDO:0957848	epstein-barr virus infectious disease	DOID:2938	MONDO:equivalentTo	Epstein-Barr virus infectious disease		MONDO:0005108
MONDO:0957878	proteosome-associated autoinflammatory syndrome	DOID:0060913	MONDO:equivalentTo	proteosome-associated autoinflammatory syndrome		MONDO:0002254
MONDO:0957879	otosclerosis 1	DOID:0060920	MONDO:equivalentTo	otosclerosis 1		MONDO:0005349
MONDO:0957880	otosclerosis 2	DOID:0060921	MONDO:equivalentTo	otosclerosis 2		MONDO:0005349
MONDO:0957881	otosclerosis 3	DOID:0060922	MONDO:equivalentTo	otosclerosis 3		MONDO:0005349
MONDO:0957882	otosclerosis 4	DOID:0060923	MONDO:equivalentTo	otosclerosis 4		MONDO:0005349
MONDO:0957883	otosclerosis 5	DOID:0060924	MONDO:equivalentTo	otosclerosis 5		MONDO:0005349
MONDO:0957884	otosclerosis 7	DOID:0060925	MONDO:equivalentTo	otosclerosis 7		MONDO:0005349
MONDO:0957885	otosclerosis 8	DOID:0060926	MONDO:equivalentTo	otosclerosis 8		MONDO:0005349
MONDO:0957886	otosclerosis 10	DOID:0060927	MONDO:equivalentTo	otosclerosis 10		MONDO:0005349
MONDO:0957887	otosclerosis 11	DOID:0060928	MONDO:equivalentTo	otosclerosis 11		MONDO:0005349
MONDO:0957888	non-syndromic x-linked intellectual developmental disorder 111	DOID:0060929	MONDO:equivalentTo	non-syndromic X-linked intellectual developmental disorder 111		MONDO:0019181
MONDO:0957889	chromosome 1p36.33 duplication syndrome	DOID:0070470	MONDO:equivalentTo	chromosome 1p36.33 duplication syndrome		MONDO:0000426|MONDO:0000762
MONDO:0957890	zaki syndrome	DOID:0070473	MONDO:equivalentTo	Zaki syndrome		MONDO:0002254|MONDO:0006025
MONDO:0957891	childhood-onset neurodegeneration with brain atrophy	DOID:0070474	MONDO:equivalentTo	childhood-onset neurodegeneration with brain atrophy		MONDO:0000426|MONDO:0005559
MONDO:0957892	mitochondrial complex iv deficiency nuclear type 23	DOID:0070485	MONDO:equivalentTo	mitochondrial complex IV deficiency nuclear type 23		MONDO:0009068|MONDO:0006025
MONDO:0957893	parkinson's disease 25	DOID:0070486	MONDO:equivalentTo	Parkinson's disease 25		MONDO:0017279|MONDO:0006025
MONDO:0957894	dopamine transporter deficiency syndrome	DOID:0070487	MONDO:equivalentTo	dopamine transporter deficiency syndrome		MONDO:0005395|MONDO:0000429
MONDO:0957895	infantile parkinsonism-dystonia 2	DOID:0070490	MONDO:equivalentTo	infantile parkinsonism-dystonia 2		MONDO:0005395|MONDO:0006025
MONDO:0957896	metabolic dysfunction and alcohol associated liver disease	DOID:0070508	MONDO:equivalentTo	metabolic dysfunction and alcohol associated liver disease		MONDO:0004790
MONDO:0957897	schinzel giedion syndrome	DOID:0070509	MONDO:equivalentTo	Schinzel Giedion syndrome		MONDO:0000426|MONDO:0019287
MONDO:0957898	inflammatory poikiloderma with hair abnormalities and acral keratoses	DOID:0070510	MONDO:equivalentTo	inflammatory poikiloderma with hair abnormalities and acral keratoses		MONDO:0006025|MONDO:0005093
MONDO:0957899	polyhydramnios, megalencephaly, and symptomatic epilepsy	DOID:0070511	MONDO:equivalentTo	polyhydramnios, megalencephaly, and symptomatic epilepsy		MONDO:0006025|MONDO:0002254
MONDO:0957900	neurodevelopmental disorder with hypotonia and speech delay	DOID:0070512	MONDO:equivalentTo	neurodevelopmental disorder with hypotonia and speech delay		MONDO:0002254|MONDO:0000429
MONDO:0957901	neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities	DOID:0070513	MONDO:equivalentTo	neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities		MONDO:0015802
MONDO:0957902	neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	DOID:0070514	MONDO:equivalentTo	neurodevelopmental disorder with dysmorphic facies and distal limb anomalies		MONDO:0015802
MONDO:0957903	chromosome 16p11.2 deletion syndrome, 593-kb	DOID:0070515	MONDO:equivalentTo	chromosome 16p11.2 deletion syndrome, 593-kb		MONDO:0000761
MONDO:0957904	mitchell syndrome	DOID:0070516	MONDO:equivalentTo	Mitchell syndrome		MONDO:0019053|MONDO:0000426
MONDO:0957905	ataxia-oculomotor apraxia type 4	DOID:0081383	MONDO:equivalentTo	ataxia-oculomotor apraxia type 4	An autosomal recessive cerebellar ataxia that is characterized by onset of dystonia and ataxia in the first decade and that has_material_basis_in homozygous or compound heterozygous mutation in the PNKP gene on chromosome 19q13.	MONDO:0015244
MONDO:0957906	ataxia-telangiectasia-like disorder-1	DOID:0081384	MONDO:equivalentTo	ataxia-telangiectasia-like disorder-1	An autosomal recessive cerebellar ataxia that is characterized clinically by progressive cerebellar degeneration resulting in ataxia and oculomotor apraxia and that has_material_basis_in homozygous or compound heterozygous mutation in the MRE11A gene (MRE11) on chromosome 11q21.	MONDO:0015244
MONDO:0957907	ataxia-telangiectasia-like disorder-2	DOID:0081385	MONDO:equivalentTo	ataxia-telangiectasia-like disorder-2	An autosomal recessive cerebellar ataxia that is characterized by developmental delay, ataxia, and sensorineural hearing loss and that has_material_basis_in homozygous mutation in the PCNA gene on chromosome 20p12.	MONDO:0015244
MONDO:0957908	tango2-related metabolic encephalopathy and arrythmias	DOID:0081386	MONDO:equivalentTo	TANGO2-related metabolic encephalopathy and arrythmias	A syndrome that is characterized by episodic metabolic degeneration affecting skeletal muscle, cardiac muscle, and the nervous system and that has_material_basis_in homozygous or compound heterozygous mutation in the TANGO2 gene on chromosome 22q11.	MONDO:0002254|MONDO:0006025
MONDO:0957909	neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities	DOID:0081387	MONDO:equivalentTo	neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities	An autosomal recessive intellectual developmental disorder that is characterized by the onset of features in infancy or early childhood and that has_material_basis_in homozygous or compound heterozygous mutation in the INTS11 gene on chromosome 1p36.	MONDO:0019502
MONDO:0957910	primary progressive aphasia	DOID:0081388	MONDO:equivalentTo	primary progressive aphasia	A frontotemporal dementia that characterized by the progressive onset of language impairments, and gradual deterioration of these abilities over time, associated with atrophy of the language network of the brain, including frontal, temporal, and parietal regions of the left hemisphere. It is caused by a loss of tissue (atrophy) in the area of the brain that is responsible for producing language.	MONDO:0017276
MONDO:0957911	corticobasal degeneration syndrome	DOID:0081392	MONDO:equivalentTo	corticobasal degeneration syndrome	A frontotemporal dementia that characterized by the loss of cognitive functions such as the ability to think, remember, or reason to the point that it interferes with a person's daily life and activities.	MONDO:0017276
MONDO:0957912	organophosphate-induced delayed polyneuropathy	DOID:0081393	MONDO:equivalentTo	organophosphate-induced delayed polyneuropathy	An inflammatory and toxic neuropathy that is characaterized by a collection of neuropsychological symptoms associated with repeated organophosphate pesticide exposure as well as nerve agent exposure. Symptoms can appear weeks after exposure and include muscle weakness, anxiety, depression, psychosis as well as cognitive and memory deficits.	MONDO:0002336
MONDO:0957913	caroli syndrome	DOID:0081394	MONDO:equivalentTo	Caroli syndrome	A syndrome that is characterized by the presence of associated congenital hepatic fibrosis and that is associated with autosomal recessive polycystic kidney disease.	MONDO:0004634|MONDO:0002887|MONDO:0002405|MONDO:0002254|MONDO:0006025
MONDO:0957914	harel-yoon syndrome	DOID:0081395	MONDO:equivalentTo	Harel-Yoon syndrome	A syndrome that is characterized by delayed psychomotor development, intellectual disability, truncal hypotonia, spasticity, and peripheral neuropathy and that has_material_basis_in heterozygous mutation in the ATAD3A gene on chromosome 1p36.	MONDO:0006025|MONDO:0000426|MONDO:0002254
MONDO:0957915	neonatal lethal pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome	DOID:0081396	MONDO:equivalentTo	neonatal lethal pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome	A syndrome that is characterized in infants showing respiratory insufficiency and almost no spontaneous movement at birth, usually requiring mechanical ventilation and admission to the neonatal intensive care unit and that has_material_basis_in compound heterozygous mutation in the ATAD3A gene on chromosome 1p36.33.	MONDO:0002254|MONDO:0006025
MONDO:0957916	vissers-bodmer syndrome	DOID:0081397	MONDO:equivalentTo	Vissers-Bodmer syndrome	A syndrome that is characterized by global developmental delay with variably impaired intellectual development, speech delay, motor delay, and behavioral abnormalities apparent from infancy and that has_material_basis_in heterozygous mutation in the CNOT1 gene on chromosome 16q21.	MONDO:0002254|MONDO:0000426
MONDO:0957917	holoprosencephaly 12	DOID:0081398	MONDO:equivalentTo	holoprosencephaly 12	A holoprosencephaly that is characterized by abnormal separation of the embryonic forebrain resulting in dysmorphic facial features and often, but not always, impaired neurologic development and that has_material_basis_in heterozygous mutation in the CNOT1 gene on chromosome 16q21.	MONDO:0016296|MONDO:0000426
